Gyre Therapeutics, Inc. (GYRE)

7.865 -0.60 (-7.03%) USD  |  NASDAQ  |  Dec 11, 16:00
7.865 0.00 (0.00%) After-Hours: 18:05
More

Gyre Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for GYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Savara, Inc. Upgrade
Exelixis, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade